Effect of oxybutinine on serteralin induced sweating in patients with depressio
Phase 2
- Conditions
- Mjor depressive disorder.Depressive episode, unspecified
- Registration Number
- IRCT201101045547N1
- Lead Sponsor
- Medical sience university of hamedan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Patients with major depressive disorder according to diagnostic and statistical manual IV- TR criteria that are using serteraline as a treatment and have sweating as side effect
Exclusion criteria:
Patients with psychotic features; addiction; anxiety disorders; age under18 and above65 years old; patients with hypertension, cardiac disease, urinary problems, cataract, increased eye pressure; patient with personality disorder and patients who are taking the other medications
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sweating. Timepoint: Before intervention, 2weeks after intervention. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method